Websites targeting keyword severe asthma
6 websites are using keyword severe asthma in their content.
Total results: 6
Domains on this page: 6
Different keywords:
Results:
Co-pay Card Program - Create a Profile | XOLAIR (Omalizumab)http://portalrankings.com/info/xolaircopay.com
The XOLAIR Co-pay Card Program can help you with your co-pay for XOLAIR, a treatment for appropriate moderate to severe persistent allergic asthma patients.
- Google Analytics code: 37696723-10
- Updated On (Date): 2016-Oct-24
- Expiration time: 2019-Apr-22
- Website Registered On (Date): 2015-Apr-22
Homehttp://portalrankings.com/info/nucalahcp.com
Introducing NUCALA, an add-on maintenance treatment for patients with severe asthma aged 12 years and older with an eosinophilic phenotype.
- Updated On (Date): 2017-Jul-22
- Expiration time: 2018-Jul-22
- Website Registered On (Date): 2015-Jul-22
E-Asthma is Eosinophilic Asthmahttp://portalrankings.com/info/easthma.com
Is your severe asthma e-asthma? Read about e-asthma (eosinophilic asthma) and find out more about severe asthma and eosinophils.
- Updated On (Date): 2017-Jul-31
- Expiration time: 2018-Aug-30
- Website Registered On (Date): 2001-Aug-30
"Climate Justice Is Racial Justice Is Gender Justice"http://portalrankings.com/info/systemicchangeandjustice.wordpress.com
“Well, there’s one story I tell to help people understand intersectionality: There’s a picture I show of this young boy named Antoine, who lives in Indiantown, Florida, 3 miles from a coal-fired power plant. He has severe asthma. There’s a picture of his bag of medicines that show what he depends on to get by…
Allergic Asthma and CIU Treatment | XOLAIR® (Omalizumab)http://portalrankings.com/info/xolair.com
XOLAIR® (omalizumab) is a treatment for moderate to severe persistent allergic asthma and Chronic Idiopathic Urticaria (CIU) in appropriate patients.
- Google Analytics code: 37696723-10
- Updated On (Date): 2015-Nov-06
- Expiration time: 2017-Dec-08
- Website Registered On (Date): 1999-Dec-08
CINQAIR.com – CINQAIR® (reslizumab) Injection now approvedhttp://portalrankings.com/info/cinqair.com
CINQAIR® (reslizumab) Injection is now approved as an add-on treatment for adults (18 years and older) with severe asthma and elevated eosinophil levels
- Google Analytics code: 75273706-1
- Updated On (Date): 2017-Nov-09
- Expiration time: 2018-Nov-14
- Website Registered On (Date): 2014-Nov-14